Policy initiatives have come fast and furious at the FDA this year. While guidances on rare diseases and vaccines have consumed most of the ink, policy shifts aimed at improving FDA efficiencies and ...

End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA - - Company expects to dose first patient in global Phase 3 registrational trial, MAPKeeper 301, in mid-2026 - - Over ...

Now in its ninth year, our annual poll showcases 255 vital video essays, nominated by 72 international voters.

Association of paleopalynological data from the Nanxiong Basin, south China, and late Paleocene niche expansion in endemic Asian fossil mammals.

Targeted digital and automation investments, especially real‑time production monitoring, robotics, and warehouse systems, ...